Table 1. Study characteristics from included studies in the meta-analysis.
First author | Year | Country | Ethnicity | Cases |
Controls |
Criteria for AD diagnosis | Time of AD onset | Control type | Quality score | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Na | Ageb | Agec | Genderd | N | Ageb | Genderd | ||||||||
Dahiyat M -1 | 1999 | UK | Caucasian | 260 | 57.0 | 79.8 | 35.6 | 207 | 71.0 | 47.1 | NINCDS/ADRDA | Mixed | PB | 10 |
Dahiyat M -2 | 1999 | UK | Caucasian | 179 | 74.0 | 82.0 | 51.4 | 186 | 77.0 | 50.0 | NINCDS/ADRDA | Late | PB | 10 |
Crawford F | 2000 | USA | Caucasian | 287 | 73.0 | — | 33.0 | 120 | 73.3 | 42.0 | NINCDS/ADRDA | Late | PB | 8 |
Higuchi S | 2000 | Japan | Asian | 411 | — | 76.0 | 27.3 | 350 | 75.7 | 27.7 | NINCDS/ADRDA | Mixed | PB | 10 |
Kunugi H | 2000 | Japan | Asian | 172 | — | 74.1 | 34.3 | 165 | 57.0 | 41.2 | NINCDS/ADRDA | Mixed | HB | 6 |
Emahazion T | 2001 | Scotland | Caucasian | 121 | — | — | — | 152 | — | — | NINCDS/ADRDA | Early | PB | 11 |
Sanchez-Guerra M | 2001 | Spain | Caucasian | 301 | 71.5 | 75.2 | 34.0 | 309 | 80.3 | 29.0 | NINCDS/ADRDA | Mixed | HB | 7 |
Singleton A | 2001 | UK | Caucasian | 212 | 79.8 | — | 33.3 | 106 | 78.2 | 47.6 | NINCDS/ADRDA | Late | PB | 9 |
Tedde A | 2002 | Italy | Caucasian | 220 | 65.0 | — | 36.4 | 95 | 80.8 | 42.1 | DSM-IV | Mixed | PB | 9 |
Kalman J | 2003 | Hungary | Caucasian | 51 | — | 76.0 | 31.4 | 51 | 72.0 | 47.1 | NINCDS/ADRDA DSM-III | Late | PB | 7 |
Monastero R | 2003 | Italy | Caucasian | 149 | 69.7 | 72.0 | 38.5 | 149 | 73.3 | 38.5 | NINCDS/ADRDA | Mixed | PB | 10 |
Yang Z | 2004 | China | Asian | 68 | 72.8 | — | 38.2 | 158 | 71.2 | 50.0 | NINCDS/ADRDA DSM-III | Late | PB | 11 |
Blomqvist ME | 2005 | Sweden | Caucasian | 382 | 76.2 | — | 37.1 | 170 | 73.2 | 46.7 | NINCDS/ADRDA | Mixed | HB | 7 |
Guidi I | 2005 | Italy | Caucasian | 405 | 73.0 | — | 29.6 | 253 | 71.0 | 42.3 | NINCDS/ADRDA | Mixed | HB | 8 |
Akomolafe A -1 | 2006 | USA | Caucasian | 235 | — | 71.4 | 24.0 | 82 | 72.3 | 30.0 | NINCDS/ADRDA | Mixed | PB | 13 |
Akomolafe A -2 | 2006 | Mixede | Caucasian | 259 | — | 68.3 | 34.0 | 127 | 71.7 | 59.0 | NINCDS/ADRDA | Mixed | PB | 10 |
Zhou Y | 2006 | China | Asian | 530 | — | 71.3 | 63.0 | 601 | 71.5 | 55.9 | NINCDS/ADRDA DSM-IV | Mixed | PB | 9 |
Li H | 2008 | Canada | Caucasian | 688 | 77.8 | 71.9 | 42.4 | 681 | 73.4 | 35.6 | NINCDS/ADRDA | Mixed | PB | 15 |
Styczynska M | 2008 | Poland | Caucasian | 154 | — | 71.5 | 33.8 | 176 | 72.7 | 31.8 | NINCDS/ADRDA | Late | PB | 11 |
Wang B | 2008 | China | Asian | 338 | 77.6 | — | 51.0 | 378 | 72.9 | 58.0 | NINCDS/ADRDA DSM-III | Late | PB | 11 |
Giedraitis V | 2009 | Sweden | Caucasian | 79 | — | 80.2 | 100 | 361 | 81.8 | 100 | NINCDS/ADRDA DSM- IV | Late | PB | 10 |
Azizi Z | 2010 | Iran | Asian | 100 | 73.8 | — | 44.0 | 100 | 72.6 | 48.0 | NINCDS/ADRDA | Late | PB | 9 |
Ferlazzo N | 2011 | Italy | Caucasian | 69 | 77.2 | 42.0 | 69 | 75.6 | 34.8 | NINCDS/ADRDA | Early | PB | 10 |
DSM: the Diagnostic and Statistical Manual of Mental Disorders; NINCDS: the National Institute of Neurological Disorders and Stoke; ADRDA: Alzheimer Diseases and Related Disorders Association; MMSE: mini-mental state examination; NA: not applicable; SNP: Single Nucleotide Polymorphism; PB = population based control; HB = hospital based control.
aNumber.
bage at survey.
cage at onset of Alzheimer’s disease.
dpercentage of male.
eparticipants from four countries (Canada, Germany and Greece).